These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18287776)

  • 1. Label-free LC-MS method for the identification of biomarkers.
    Higgs RE; Knierman MD; Gelfanova V; Butler JP; Hale JE
    Methods Mol Biol; 2008; 428():209-30. PubMed ID: 18287776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive label-free method for the relative quantification of proteins from biological samples.
    Higgs RE; Knierman MD; Gelfanova V; Butler JP; Hale JE
    J Proteome Res; 2005; 4(4):1442-50. PubMed ID: 16083298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental Null Method to Guide the Development of Technical Procedures and to Control False-Positive Discovery in Quantitative Proteomics.
    Shen X; Hu Q; Li J; Wang J; Qu J
    J Proteome Res; 2015 Oct; 14(10):4147-57. PubMed ID: 26051676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a pharmaceutical hepatotoxicity biomarker panel using a discovery to targeted proteomics approach.
    Collins BC; Miller CA; Sposny A; Hewitt P; Wells M; Gallagher WM; Pennington SR
    Mol Cell Proteomics; 2012 Aug; 11(8):394-410. PubMed ID: 22527513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative protein quantification and accessible biology in lung tumor proteomes from four LC-MS/MS discovery platforms.
    Stewart PA; Fang B; Slebos RJ; Zhang G; Borne AL; Fellows K; Teer JK; Chen YA; Welsh E; Eschrich SA; Haura EB; Koomen JM
    Proteomics; 2017 Mar; 17(6):. PubMed ID: 28195392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring protein structural changes on a proteome-wide scale using limited proteolysis-coupled mass spectrometry.
    Schopper S; Kahraman A; Leuenberger P; Feng Y; Piazza I; Müller O; Boersema PJ; Picotti P
    Nat Protoc; 2017 Nov; 12(11):2391-2410. PubMed ID: 29072706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined tissue and fluid proteomics with Tandem Mass Tags to identify low-abundance protein biomarkers of disease in peripheral body fluid: An Alzheimer's Disease case study.
    Russell CL; Heslegrave A; Mitra V; Zetterberg H; Pocock JM; Ward MA; Pike I
    Rapid Commun Mass Spectrom; 2017 Jan; 31(2):153-159. PubMed ID: 27813239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative label-free proteomics for discovery of biomarkers in cerebrospinal fluid: assessment of technical and inter-individual variation.
    Perrin RJ; Payton JE; Malone JP; Gilmore P; Davis AE; Xiong C; Fagan AM; Townsend RR; Holtzman DM
    PLoS One; 2013; 8(5):e64314. PubMed ID: 23700471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Combination of DNA-peptide Probes and Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS): A Quasi-Targeted Proteomics Approach for Multiplexed MicroRNA Quantification.
    Xu F; Zhou W; Cao J; Xu Q; Jiang D; Chen Y
    Theranostics; 2017; 7(11):2849-2862. PubMed ID: 28824720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis.
    Collins MA; An J; Hood BL; Conrads TP; Bowser RP
    J Proteome Res; 2015 Nov; 14(11):4486-501. PubMed ID: 26401960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical biomarker discovery by SWATH-MS based label-free quantitative proteomics: impact of criteria for identification of differentiators and data normalization method.
    Narasimhan M; Kannan S; Chawade A; Bhattacharjee A; Govekar R
    J Transl Med; 2019 May; 17(1):184. PubMed ID: 31151397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absolute Quantification of Middle- to High-Abundant Plasma Proteins via Targeted Proteomics.
    Dittrich J; Ceglarek U
    Methods Mol Biol; 2017; 1619():417-430. PubMed ID: 28674901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is label-free LC-MS/MS ready for biomarker discovery?
    Sandin M; Chawade A; Levander F
    Proteomics Clin Appl; 2015 Apr; 9(3-4):289-94. PubMed ID: 25656266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Proteomic Analysis of Complex Mixtures by Label-Free nLC MS/MS.
    Escobés I; Azkargorta M; Iloro I; Elortza F
    Methods Mol Biol; 2022; 2471():111-121. PubMed ID: 35175593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MS1 ion current-based quantitative proteomics: A promising solution for reliable analysis of large biological cohorts.
    Wang X; Shen S; Rasam SS; Qu J
    Mass Spectrom Rev; 2019 Nov; 38(6):461-482. PubMed ID: 30920002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic evaluation of label-free and super-SILAC quantification for proteome expression analysis.
    Tebbe A; Klammer M; Sighart S; Schaab C; Daub H
    Rapid Commun Mass Spectrom; 2015 May; 29(9):795-801. PubMed ID: 26377007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isobaric Labeling-Based LC-MS/MS Strategy for Comprehensive Profiling of Human Pancreatic Tissue Proteome.
    Liu CW; Zhang Q
    Methods Mol Biol; 2018; 1788():215-224. PubMed ID: 28986817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isotope coded protein label quantification of serum proteins--comparison with the label-free LC-MS and validation using the MRM approach.
    Turtoi A; Mazzucchelli GD; De Pauw E
    Talanta; 2010 Feb; 80(4):1487-95. PubMed ID: 20082806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative bottom-up proteomics depends on digestion conditions.
    Lowenthal MS; Liang Y; Phinney KW; Stein SE
    Anal Chem; 2014 Jan; 86(1):551-8. PubMed ID: 24294946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Label-Free Quantitation for Clinical Proteomics.
    Moulder R; Goo YA; Goodlett DR
    Methods Mol Biol; 2016; 1410():65-76. PubMed ID: 26867738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.